Over 10 North Carolina Auctions End Today - Bid Now
Over 150 Total Lots Up For Auction at Three Locations - Over 40 Ohio Auctions End Tomorrow 03/06 - Bid Now, CA 03/08, CA 03/15

Johnson & Johnson anuncia el acuerdo de comprar a Mentor Corp.

por Lynn Shapiro, Writer | December 02, 2008
Johnson & Johnson to buy
Mentor Corporation
Johnson & Johnson said it would pay $1.07 billion in cash to buy Mentor Corporation, a supplier of breast implants and other cosmetic products.

Under the terms of the agreement, J&J will purchase all outstanding shares of Mentor at $31.00 per share, a premium of $14.85, or 92 percent, over Mentor's closing price last Friday of $16.15. After announcing the purchase, Mentor's stock leapt 90 percent to $30.71. J&J's stock fell 2.7 percent to $57.03.

This is the second acquisition J&J has announced in the last week. In November, J&J said it would acquire biotech company Omrix Biopharmacueticals Inc. for $438 million to grow its surgical care business. Now that many biotech and healthcare companies are at market lows, Wall Street expects the company to ink more deals in the near future.
stats
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

stats
Mentor is expected to operate as a stand-alone business unit reporting through Ethicon, Inc., J&J's subsidiary that is a leading provider of suture, mesh and other surgical products.

Upon closing, the transaction is expected to have a dilutive impact to Johnson & Johnson's 2009 earnings per share of approximately $.03-$.05. The merger is expected to close in the first quarter of 2009.